Back
ESC Premium Access

The endocannabinoid system is a novel therapeutic target for muscular dystrophy cardiomyopathy.

Session: Best Posters 4 - Best Posters in genomics to therapy
Topic: Stem cells and cell therapy
Speaker: Doctor A. Gowran (Milan, IT)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Aoife Gowran

Monzino Cardiology Centre, Milan (Italy)
0 follower

4 more presentations in this session

Discussant: Best Posters in genomics to therapy

Access
Like
Thumbnail

Systematic analysis of cardiac disease genes in pediatric cardiomyopathy patients identifies novel genetic variants.

Speaker: Doctor J. Kuehnisch (Berlin, DE)

Access
Abstract
Slides
Like
Thumbnail

Polymorphisms of the ALOX5AP gene (5-lipoxygenase activating protein) are associated with increased cardiovascular risk in patients with acute coronary syndrome: Analysis of PLATO genetics sub-study.

Speaker: Doctor C. Balendran (Gothenburg, SE)

Access
Abstract
Like
Thumbnail

Investigating dilated cardiomyopathy caused by dystrophin mutations using duchenne muscular dystrophy-patients induced pluripotent stem cell-derived cardiomyocytes

Speaker: Mr B. Eisen (Haifa, IL)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Best Posters 4 - Best Posters in genomics to therapy

Speakers: Doctor A. Gowran, Doctor J. Kuehnisch, Doctor C. Balendran, Mr B. Eisen
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources